WealthTrust Axiom LLC Lowers Position in Omega Healthcare Investors, Inc. $OHI

Key Points

• WealthTrust Axiom LLC has reduced its stake in Omega Healthcare Investors, Inc. by 26.8%, selling 6,100 shares and ending with 16,700 shares valued at $636,000.
• The company's recent quarterly earnings showed $0.77 earnings per share, surpassing estimates of $0.45, with revenue reaching $235.6 million but falling short of expectations.
• Omega Healthcare Investors announced a quarterly dividend of $0.67 per share, indicating a 6.4% yield, although its payout ratio stands high at 165.43%.

WealthTrust Axiom LLC trimmed its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 26.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,700 shares of the real estate investment trust's stock after selling 6,100 shares during the quarter. WealthTrust Axiom LLC's holdings in Omega Healthcare Investors were worth $636,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. NBC Securities Inc. purchased a new position in Omega Healthcare Investors during the first quarter valued at $29,000. Dunhill Financial LLC increased its stake in shares of Omega Healthcare Investors by 97.9% in the 4th quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust's stock worth $57,000 after acquiring an additional 750 shares in the last quarter. CoreCap Advisors LLC lifted its position in Omega Healthcare Investors by 177.3% during the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock valued at $60,000 after acquiring an additional 1,009 shares during the period. Park Square Financial Group LLC bought a new stake in Omega Healthcare Investors during the fourth quarter worth about $61,000. Finally, UMB Bank n.a. increased its stake in shares of Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Trading Down 0.4%

Shares of OHI stock opened at $42.20 on Monday. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The stock has a market capitalization of $12.45 billion, a P/E ratio of 26.05, a P/E/G ratio of 2.24 and a beta of 0.66. The firm's 50 day moving average is $38.50 and its 200 day moving average is $37.60.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company's revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 6.4%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's payout ratio is currently 165.43%.

Insider Buying and Selling

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares of the company's stock, valued at $749,144.64. The trade was a 11.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

OHI has been the topic of a number of recent research reports. Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Wells Fargo & Company raised shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $38.00 to $41.00 in a research report on Monday, July 14th. Four investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $42.00.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.